Terms: = Uterine cancer AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Prognosis
1982 results:
1. Efficacy and safety of chemotherapy as monotherapy in patients with recurrent intermediate/high-risk factors following radical hysterectomy for stage IB-IIA cervical cancer: a single-center retrospective analysis.
Dong B; Zhou SF
BMC Womens Health; 2024 May; 24(1):297. PubMed ID: 38762459
[TBL] [Abstract] [Full Text] [Related]
2. Radiomic profiles improve prognostication and reveal targets for therapy in cervical cancer.
Halle MK; Hodneland E; Wagner-Larsen KS; Lura NG; Fasmer KE; Berg HF; Stokowy T; Srivastava A; Forsse D; Hoivik EA; Woie K; Bertelsen BI; Krakstad C; Haldorsen IS
Sci Rep; 2024 May; 14(1):11339. PubMed ID: 38760387
[TBL] [Abstract] [Full Text] [Related]
3. Development and assessment of an RNA editing-based risk model for the prognosis of cervical cancer patients.
Zhu Z; Lu J
Medicine (Baltimore); 2024 May; 103(19):e38116. PubMed ID: 38728474
[TBL] [Abstract] [Full Text] [Related]
4. Clinical analysis of 314 patients with high-grade squamous intraepithelial lesion who underwent total hysterectomy directly: a multi-center, retrospective cohort study.
Lei L; Zhang L; Zheng Y; Ma W; Liu F; Li D; Chen K; Zeng Y
BMC Cancer; 2024 May; 24(1):575. PubMed ID: 38724921
[TBL] [Abstract] [Full Text] [Related]
5. Clinical Outcomes and Prognostic Factors in Stage III C Cervical cancer Patients Treated with Radical Radiotherapy or Radiochemotherapy.
Zhang W; Yu H; Xiu Y; Meng F; Wang Z; Zhao K; Wang Y; Chen Z; Liu J; Chen J; Sun B
Technol Cancer Res Treat; 2024; 23():15330338241254075. PubMed ID: 38720626
[No Abstract] [Full Text] [Related]
6. Total hysterectomy versus radical hysterectomy in neuroendocrine cervical cancer: a SEER-database analysis.
Zeng F; Guo P; Xia M; He M
J Cancer Res Clin Oncol; 2024 May; 150(5):236. PubMed ID: 38710946
[TBL] [Abstract] [Full Text] [Related]
7. METTL3-mediated m
Liu HT; Zhao Y; Wang HC; Liu QL
Biochem Biophys Res Commun; 2024 Jul; 716():150039. PubMed ID: 38701556
[TBL] [Abstract] [Full Text] [Related]
8. Prevalence of high-risk human papillomavirus infection among women with diabetes mellitus in Accra, Ghana.
Atiase Y; Effah K; Mawusi Wormenor C; Tekpor E; Aku Catherine Morkli E; Boafo E; Yorke E; Aryee R; Essel NOM; Danyo S; Kemawor S; Akpalu J
BMC Womens Health; 2024 Apr; 24(1):260. PubMed ID: 38664791
[TBL] [Abstract] [Full Text] [Related]
9. [Establishment of a prognostic nomogram and discussion on optimal treatment for cervical adenocarcinoma:a retrospective study based on SEER database and Chinese single-center data].
Li X; Gao YH; Yang Z; Ma Y; Liu C; Liu GC; Wang DB
Zhonghua Fu Chan Ke Za Zhi; 2024 Apr; 59(4):307-319. PubMed ID: 38644277
[No Abstract] [Full Text] [Related]
10. Sarcoma of the uterine cervix: experience of a single center.
Yuan H; Li L; Li N; Yao H
World J Surg Oncol; 2024 Apr; 22(1):104. PubMed ID: 38637834
[TBL] [Abstract] [Full Text] [Related]
11. Characteristics of patients with late recurrence endometrial cancer.
Çakır İ; Gülseren V; Özdemir İA; Abacı H; Talu ECK; Çakır ZE; Ata C; Kuru O; Gökçü M; Sancı M; Güngördük K
J Cancer Res Ther; 2024 Jan; 20(1):232-237. PubMed ID: 38554326
[TBL] [Abstract] [Full Text] [Related]
12. A retrospective study of the effects of uterine manipulators on prognosis in patients with cervical cancer.
Guo X; Zhao E; Guan Z; Li W; Zhang J; Tian S; Yao Y
J Int Med Res; 2024 Mar; 52(3):3000605241233966. PubMed ID: 38553028
[TBL] [Abstract] [Full Text] [Related]
13. [Postoperative lymph node metastasis status and related factors in patients with early-stage, low-risk endometrial cancer assessed by the Mayo criteria].
Shi XW; Wang DF; Zhang GN; Zhang J
Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(10):736-741. PubMed ID: 38462353
[No Abstract] [Full Text] [Related]
14. Antiproliferative activities of some selected Nigerian medicinal plants against breast, liver, and cervical cancer cells.
Olaleye OO; Kim DH; Spriggs KA
BMC Complement Med Ther; 2024 Mar; 24(1):110. PubMed ID: 38448883
[TBL] [Abstract] [Full Text] [Related]
15. The expression analysis of human endogenous retrovirus-K Env, Np9, and Rec transcripts in cervical cancer.
Soleimani-Jelodar R; Arashkia A; Shoja Z; Akhavan S; Yarandi F; Sharifian K; Farahmand M; Nili F; Jalilvand S
J Med Virol; 2024 Mar; 96(3):e29501. PubMed ID: 38445563
[TBL] [Abstract] [Full Text] [Related]
16. Immunohistochemical p16 overexpression and Rb loss correlate with high-risk human papillomavirus infection in endocervical adenocarcinomas.
Yasutake N; Yamamoto H; Kuga R; Jiromaru R; Hongo T; Katayama Y; Sonoda K; Yahata H; Kato K; Oda Y
Histopathology; 2024 Jun; 84(7):1178-1191. PubMed ID: 38445509
[TBL] [Abstract] [Full Text] [Related]
17. Dendritic cell vaccination combined with carboplatin/paclitaxel for metastatic endometrial cancer patients: results of a phase I/II trial.
Koeneman BJ; Schreibelt G; Gorris MAJ; Hins-de Bree S; Westdorp H; Ottevanger PB; de Vries IJM
Front Immunol; 2024; 15():1368103. PubMed ID: 38444861
[TBL] [Abstract] [Full Text] [Related]
18. Clinical features and impact of p53 status on sporadic mismatch repair deficiency and Lynch syndrome in uterine cancer.
Kato MK; Fujii E; Asami Y; Momozawa Y; Hiranuma K; Komatsu M; Hamamoto R; Ebata T; Matsumoto K; Ishikawa M; Kohno T; Kato T; Yoshida H; Shiraishi K
Cancer Sci; 2024 May; 115(5):1646-1655. PubMed ID: 38433331
[TBL] [Abstract] [Full Text] [Related]
19. Retrospective Analysis of All Types of Adjuvant Radiotherapy in Endometrial cancer: Single-Center Experiences in a Middle-Income Country.
Chitapanarux N; Tharavichitkul E; Kittidachanan K; Muangwong P; Chakrabandhu S; Klunklin P; Onchan W; Jia-Mahasap B; Torapichattrakul P; Chitapanarux I
Asian Pac J Cancer Prev; 2024 Feb; 25(2):485-494. PubMed ID: 38415534
[TBL] [Abstract] [Full Text] [Related]
20. The significance of lower uterine segment involvement in endometrial cancer.
Davidesko S; Meirovitz M; Shaco-Levy R; Yarza S; Samueli B; Kezerle Y; Kessous R
Eur J Surg Oncol; 2024 Mar; 50(3):108007. PubMed ID: 38382274
[TBL] [Abstract] [Full Text] [Related]
[Next]